๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach

โœ Scribed by M. Rocchetti; F. Del Bene; M. Germani; F. Fiorentini; I. Poggesi; E. Pesenti; P. Magni; G. De Nicolao


Book ID
116430189
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
769 KB
Volume
45
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Clinical studies in the development of n
โœ Ferry A.L.M Eskens; Jaap Verweij ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 72 KB

Various new specifically targeted anticancer agents such as matrixmetalloproteinase inhibitors, angiogenesis inhibitors, farnesyl transferase inhibitors, and tyrosine kinase inhibitors have been developed in recent years. These agents exert antitumor activity through specific target inhibition, and